awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26783253-6273F360-81D7-4791-A831-1B02F72519EC
Q26783253-6273F360-81D7-4791-A831-1B02F72519EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26783253-6273F360-81D7-4791-A831-1B02F72519EC
Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS
P2860
Q26783253-6273F360-81D7-4791-A831-1B02F72519EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26783253-6273F360-81D7-4791-A831-1B02F72519EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a10d3b39f744fa71b24b039a0d30587768d44dec
P2860
A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 results.